Mrs Saga Itainen-Stromberg
Helsinki University Hospital, Helsinki (Finland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
How much does elective cardioversion increase the risk of ischaemic stroke compared to the baseline risk in atrial fibrillation? A nationwide study.
Event: ESC Congress 2024
Topic: Rhythm Control, Cardioversion
Session: Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians
Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland
Event: ESC Congress 2022
Topic: Rhythm Control, Cardioversion
Session: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation
Oral anticoagulation in patients undergoing elective cardioversion of atrial fibrillation. Real-life experience from Finland
Event: ESC Congress 2019
Topic: Rhythm Control, Cardioversion
Session: Drug treatment for atrial fibrillation
Direct oral anticoagulants in atrial fibrillation patients undergoing cardioversion. Nationwide multicentre study.
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: New trends in antithrombotic therapy for atrial fibrillation
